214 related articles for article (PubMed ID: 34972157)
1. Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data.
Carey IM; Banchoff E; Nirmalananthan N; Harris T; DeWilde S; Chaudhry UAR; Cook DG
PLoS One; 2021; 16(12):e0261983. PubMed ID: 34972157
[TBL] [Abstract][Full Text] [Related]
2. A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort.
Megarbane A; Bizzari S; Deepthi A; Sabbagh S; Mansour H; Chouery E; Hmaimess G; Jabbour R; Mehawej C; Alame S; Hani A; Hasbini D; Ghanem I; Koussa S; Al-Ali MT; Obeid M; Talea DB; Lefranc G; Lévy N; Leturcq F; El Hayek S; Delague V; Urtizberea JA
J Neuromuscul Dis; 2022; 9(1):193-210. PubMed ID: 34602496
[TBL] [Abstract][Full Text] [Related]
3. Descriptive epidemiology of selected neuromuscular disorders in Benghazi, Libya.
Radhakrishnan K; el-Mangoush MA; Gerryo SE
Acta Neurol Scand; 1987 Feb; 75(2):95-100. PubMed ID: 3472424
[TBL] [Abstract][Full Text] [Related]
4. [Clinico-epidemiological aspects of hereditary neuromuscular diseases in the Krasnodar territory].
Krivopusk ME
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):3-5. PubMed ID: 1664610
[TBL] [Abstract][Full Text] [Related]
5. Trends in incidence, prevalence, and mortality of neuromuscular disease in Ontario, Canada: A population-based retrospective cohort study (2003-2014).
Rose L; McKim D; Leasa D; Nonoyama M; Tandon A; Bai YQ; Amin R; Katz S; Goldstein R; Gershon A
PLoS One; 2019; 14(3):e0210574. PubMed ID: 30913206
[TBL] [Abstract][Full Text] [Related]
6. Prevalence studies of multiple sclerosis, myasthenia gravis, and myopathies in Kumamoto district, Japan.
Araki S; Uchino M; Kumamoto T
Neuroepidemiology; 1987; 6(3):120-9. PubMed ID: 3658081
[TBL] [Abstract][Full Text] [Related]
7. Acute Neuromuscular Disorders in the Pediatric Intensive Care Unit.
Harrar DB; Darras BT; Ghosh PS
J Child Neurol; 2020 Jan; 35(1):17-24. PubMed ID: 31502491
[TBL] [Abstract][Full Text] [Related]
8. Charcot-Marie-Tooth disease in Denmark: a nationwide register-based study of mortality, prevalence and incidence.
Vaeth S; Vaeth M; Andersen H; Christensen R; Jensen UB
BMJ Open; 2017 Nov; 7(11):e018048. PubMed ID: 29101144
[TBL] [Abstract][Full Text] [Related]
9. MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study.
Morrow JM; Sinclair CD; Fischmann A; Machado PM; Reilly MM; Yousry TA; Thornton JS; Hanna MG
Lancet Neurol; 2016 Jan; 15(1):65-77. PubMed ID: 26549782
[TBL] [Abstract][Full Text] [Related]
10. Sepsis recording in primary care electronic health records, linked hospital episodes and mortality records: Population-based cohort study in England.
Rezel-Potts E; Gulliford MC;
PLoS One; 2020; 15(12):e0244764. PubMed ID: 33382845
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county.
Ahlström G; Gunnarsson LG; Leissner P; Sjödén PO
Neuroepidemiology; 1993; 12(5):262-9. PubMed ID: 8309501
[TBL] [Abstract][Full Text] [Related]
12. A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland.
Lefter S; Hardiman O; Ryan AM
Neurology; 2017 Jan; 88(3):304-313. PubMed ID: 27927941
[TBL] [Abstract][Full Text] [Related]
13. Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study.
Gulliford MC; Juszczyk D; Prevost AT; Soames J; McDermott L; Sultana K; Wright M; Fox R; Hay AD; Little P; Moore M; Yardley L; Ashworth M; Charlton J
Health Technol Assess; 2019 Mar; 23(11):1-70. PubMed ID: 30900550
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of myasthenia gravis in Ontario, Canada.
Breiner A; Widdifield J; Katzberg HD; Barnett C; Bril V; Tu K
Neuromuscul Disord; 2016 Jan; 26(1):41-6. PubMed ID: 26573434
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data.
Keovilayhong S; Mulliez A; Feral L; Chenaf C; Clavelou P; Moisset X; Taithe F; Poncet Megemont L
Rev Neurol (Paris); 2024 May; 180(5):451-458. PubMed ID: 38582663
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.
Santos E; Coutinho E; Moreira I; Silva AM; Lopes D; Costa H; Silveira F; Nadais G; Morais H; Martins J; Branco MC; Veiga A; Silva RS; Ferreira A; Sousa F; Freijo M; Matos I; André R; Negrão L; Fraga C; Santos M; Sampaio M; Lopes C; Leite MI; Gonçalves G
Muscle Nerve; 2016 Sep; 54(3):413-21. PubMed ID: 26851892
[TBL] [Abstract][Full Text] [Related]
17. [Cardiac involvement in neuromuscular diseases].
Posada Rodríguez IJ; Gutiérrez-Rivas E; Cabello A
Rev Esp Cardiol; 1997 Dec; 50(12):882-901. PubMed ID: 9470454
[TBL] [Abstract][Full Text] [Related]
18. Nationwide population-based epidemiological study of myasthenia gravis in taiwan.
Lai CH; Tseng HF
Neuroepidemiology; 2010; 35(1):66-71. PubMed ID: 20523074
[TBL] [Abstract][Full Text] [Related]
19. Incidence and prevalence of acromegaly in a large US health plan database.
Burton T; Le Nestour E; Neary M; Ludlam WH
Pituitary; 2016 Jun; 19(3):262-7. PubMed ID: 26792654
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
